Inspire Medical Systems
INSP
373 hedge funds and large institutions have $6.68B invested in Inspire Medical Systems in 2023 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 156 increasing their positions, 101 reducing their positions, and 28 closing their positions.
129% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 28
54% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 101
11% more call options, than puts
Call options by funds: $41.3M | Put options by funds: $37.3M
10% more funds holding
Funds holding: 340 → 373 (+33)
1.25% more ownership
Funds ownership: 97.63% → 98.88% (+1.3%)
6% less capital invested
Capital invested by funds: $7.1B → $6.68B (-$424M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$89.2M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$67.9M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$53.7M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$46.6M |
| 5 |
Renaissance Technologies
New York
|
+$43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$117M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$82.7M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$75.5M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$61.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$55.7M |
INSP Hedge Fund Activity: Q1 2023 in Review
373 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2023, worth a combined $6.68B — down 6% from $7.1B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new INSP positions and 28 closed out — a net gain of 36 holders — while 156 added to existing stakes and 101 trimmed.
The largest buyer was Invesco, adding an estimated $89.2M. The largest seller was Macquarie Group, cutting an estimated $117M.
- 373 institutional investors held Inspire Medical Systems (INSP) as of Q1 2023, up from 340 in Q4 2022.
- Funds reported $6.68B of Inspire Medical Systems stock for Q1 2023, down 6% quarter-over-quarter.
- 64 funds opened new Inspire Medical Systems positions in Q1 2023 and 28 closed out, a net change of +36 holders.
- The largest Inspire Medical Systems buyer in Q1 2023 was Invesco, an estimated $89.2M added.
- The largest Inspire Medical Systems seller in Q1 2023 was Macquarie Group, an estimated $117M sold.
Based on aggregated 13F filings for Q1 2023.